Blue Shield of California
Other
Active
San Francisco, United States
9
99M
7
0.11
0.22
1
- Areas of investment
Summary
The main department of described Corporate Investor is located in the San Francisco. The company was established in North America in United States.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Cardinal Analytx Solutions, OODA Health The fund has no exact preference in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Life Science, Medical.
The usual cause for the fund is to invest in rounds with 3 partakers. Despite the Blue Shield of California, startups are often financed by StartX (Stanford-StartX Fund), Premera Blue Cross, Cardinal Partners. The meaningful sponsors for the fund in investment in the same round are Threshold, Premera Blue Cross, Oak HC/FT.
The top activity for fund was in 2019. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The fund was created by Natalie Cann.
Investor highlights
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 9
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.11
- Follow on index
- 0.22
- Investments by industry
- Health Care (9)
- Medical (5)
- Home Health Care (4)
- Child Care (2)
- mHealth (2) Show 9 more
- Investments by region
-
- United States (9)
- Peak activity year
- 2022
- Number of Unicorns
- 1
- Number of Decacorns
- 1
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Avg. valuation at time of investment
- 360M
- Group Appearance index
- 1.00
- Avg. company exit year
- 4
- Avg. multiplicator
- 10.00
- Strategy success index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Ryse Health | 08 Apr 2022 | Health Care, Medical | Seed | 3M | United States, Virginia, Arlington |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.